CoChat

Amyloidogenesis of SARS-CoV-2 Spike Protein

Open access
Nyström, Sofie, Hammarström, Per · 2021 · Journal of the American Chemical Society

Preprint — published as 10.1021/jacs.2c03925

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

SARS-CoV-2 infection is associated with a surprising number of morbidities. Uncanny similarities with amyloid-disease associated blood coagulation and fibrinolytic disturbances together with neurologic and cardiac problems led us to investigate the amyloidogenicity of the SARS-CoV-2 Spike protein (S-protein). Amyloid fibril assays of peptide library mixtures and theoretical predictions identified seven amyloidogenic sequences within the S-protein. All seven peptides in isolation formed aggregates during incubation at 37°C. Three 20-amino acid long synthetic Spike peptides (sequence 191-210, 599-618, 1165-1184) fulfilled three amyloid fibril criteria: nucleation dependent polymerization kinetics by ThT, Congo red positivity and ultrastructural fibrillar morphology. Full-length folded S-protein did not form amyloid fibrils, but amyloid-like fibrils with evident branching were formed during 24 hours of S-protein co-incubation with the protease neutrophil elastase (NE) in vitro. NE efficiently cleaved S-protein rendering exposure of amyloidogenic segments and accumulation of the peptide 193-202, part of the most amyloidogenic synthetic Spike peptide. NE is overexpressed at inflamed sites of viral infection and at vaccine injection sites. Our data propose a molecular mechanism for amyloidogenesis of SARS-CoV-2 S-protein in humans facilitated by endoproteolysis. The potential implications of S-protein amyloidogenesis in COVID-19 disease associated pathogenesis and consequences following S-protein based vaccines should be addressed in understanding the disease, long COVID-19, and vaccine side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.12.16.472920

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Amyloid fibril assays of SARS-CoV-2 S peptides (0.1 mg/mL). (A) ThT fluorescence fibril formation kinetics. (B) Congo red birefringence microscopy. (C) Negative stain TEM ultrastructure.
Figure 1 Amyloid fibril assays of SARS-CoV-2 S peptides (0.1 mg/mL). (A) ThT fluorescence fibril formation kinetics. (B) Congo red birefringence microscopy. (C) Negative stain TEM ultrastructure.CC BY · PubMed Central
Figure 2 S-protein proteolysis by NE renders amyloid-like fibrils. Thermostability of (A) SARS-CoV-2 S-protein, (B) NE, (C) S-protein+NE, measured by DSF. Dashed line in (C) is the mathematical sum of S-protein and NE, respectively, from (A) and (B) supporting cleavage of S-protein by NE. MALDI-ToF spectra of C18 isolated peptides of (D) S-protein, (E) NE, and (F) S-protein+NE (6 h, 37 °C). TEM micrographs of (G) S-protein alone depicting the expected trimers, (H) NE alone, and (I) S-protein+NE coincubated at pH 8.4, 24 h, 37 °C.
Figure 2 S-protein proteolysis by NE renders amyloid-like fibrils. Thermostability of (A) SARS-CoV-2 S-protein, (B) NE, (C) S-protein+NE, measured by DSF. Dashed line in (C) is the mathematical sum of S-protein and NE, respectively, from (A) and (B) supporting cleavage of S-protein by NE. MALDI-ToF spectra of C18 isolated peptides of (D) S-protein, (E) NE, and (F) S-protein+NE (6 h, 37 °C). TEM micrographs of (G) S-protein alone depicting the expected trimers, (H) NE alone, and (I) S-protein+NE coincubated at pH 8.4, 24 h, 37 °C.CC BY · PubMed Central
Figure 3 NE cleavage sites within full-length S-protein. Arrows indicate limits of the cryo-EM structure 27–1146. (A) Peptides identified by LC-MS/MS (Table S1) in correlation to the amyloidogenic Spike peptides (cf. Figure 1 and Table 1) and the S-protein domain structure: after (i) 1 min (red), (ii) 1 min and still persistent at 6 h (magenta), (iii) only present after 6 h incubation (blue). (B–E) Same color code for cleaved peptide groups (i)–(iii) and spike peptides mapped onto the protomer cryo-EM S-protein structure PDB 6VXX.1
Figure 3 NE cleavage sites within full-length S-protein. Arrows indicate limits of the cryo-EM structure 27–1146. (A) Peptides identified by LC-MS/MS (Table S1) in correlation to the amyloidogenic Spike peptides (cf. Figure 1 and Table 1) and the S-protein domain structure: after (i) 1 min (red), (ii) 1 min and still persistent at 6 h (magenta), (iii) only present after 6 h incubation (blue). (B–E) Same color code for cleaved peptide groups (i)–(iii) and spike peptides mapped onto the protomer cryo-EM S-protein structure PDB 6VXX.1CC BY · PubMed Central
Figure 4 (A) Spike194–203 properties. (B) Spike194–203 amyloidogenicity monitored by ThT kinetics, Congo red birefringence, and TEM. (C) Thrombin activated fibrin formation and plasminogen/tPA-induced fibrinolysis in the absence and presence of seven-peptide-mix amyloid fibrils (Table 1, Figure S3). (D) Turbidity difference after fibrin formation and fibrinolysis in the absence and presence of Spike192 fibrils and Spike194–203 fibrils (n = 10–12 replicates of each reaction, corrected for background scatter).
Figure 4 (A) Spike194–203 properties. (B) Spike194–203 amyloidogenicity monitored by ThT kinetics, Congo red birefringence, and TEM. (C) Thrombin activated fibrin formation and plasminogen/tPA-induced fibrinolysis in the absence and presence of seven-peptide-mix amyloid fibrils (Table 1, Figure S3). (D) Turbidity difference after fibrin formation and fibrinolysis in the absence and presence of Spike192 fibrils and Spike194–203 fibrils (n = 10–12 replicates of each reaction, corrected for background scatter).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 24

  1. 10.1016/j.cell.2007.10.014 · DOI · Paper page
  2. Tayeb-Fligelman, E. , et al., Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2. bioRxiv, 2021. · DOI
  3. 2021, Mechanisms and therapeutic potential of interactions between human amyloids and viruses, Cell Mol Life Sci, 78, 2485, 10.1007/s00018-020-03711-8 · DOI
  4. 2020, Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection, ACS Chem Neurosci, 11, 3704, 10.1021/acschemneuro.0c00676 · DOI
  5. 2018, Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein, Int J Biochem Cell Biol, 101, 103, 10.1016/j.biocel.2018.05.012 · DOI
  6. 2021, SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration, Biochem Biophys Res Commun, 554, 94, 10.1016/j.bbrc.2021.03.100 · DOI
  7. 10.1038/nmeth.1432 · DOI · Paper page
  8. 2021, Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants, J Biol Chem, 297, 101208, 10.1016/j.jbc.2021.101208 · DOI
  9. 10.1080/13506129.2020.1835263 · DOI · Paper page
  10. Sipe, J.D. , Amyloid proteins : the beta sheet conformation and disease. 2005, Weinheim: Wiley-VCH; [Chichester : John Wiley, distributor]. · DOI
  11. 2021, The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets, Nat Microbiol, 6, 899, 10.1038/s41564-021-00908-w · DOI · Paper page
  12. 2021, Neutrophils in respiratory viral infections, Mucosal Immunol, 14, 815, 10.1038/s41385-021-00397-4 · DOI · Paper page
  13. 10.3389/fphar.2017.00512 · DOI
  14. 2020, Alpha1-Antitrypsin Deficiency, N Engl J Med, 382, 1443, 10.1056/NEJMra1910234 · DOI · Paper page
  15. 2021, Cold sensitivity of the SARS-CoV-2 spike ectodomain, Nat Struct Mol Biol, 28, 128, 10.1038/s41594-020-00547-5 · DOI
  16. 10.1016/S0140-6736(20)32656-8 · DOI · Paper page
  17. 10.3389/fimmu.2021.627579 · DOI
  18. 2021, Cytokine storm syndrome in coronavirus disease 2019: A narrative review, J Intern Med, 289, 147, 10.1111/joim.13144 · DOI · Paper page
  19. 2021, Likelihood of amyloid formation in COVID-19-induced ARDS, Trends Microbiol, 29, 967, 10.1016/j.tim.2021.03.008 · DOI
  20. Grobbelaar, L.M. , et al., SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep, 2021. 41(8). · DOI · Paper page
  21. 2007, The bloody path of amyloids and prions, J Thromb Haemost, 5, 1136, 10.1111/j.1538-7836.2007.02575.x · doi:10.1111/j.1538-7836.2007.02575.x
  22. 2007, Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses, J Thromb Haemost, 5, 1139, 10.1111/j.1538-7836.2007.02457.x · DOI
  23. 2008, Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation, J Clin Invest, 118, 3208
  24. Laudicella, R. , et al., Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination. SN Compr Clin Med, 2021: p. 1–3. · DOI

Metadata

Authors
Nyström, S., & Hammarström, P.
Affiliations
Linköping University (SE)
Corresponding author
  • Nyström, Sofie
  • Hammarström, Per
Venue
Journal of the American Chemical Society
Publisher
openRxiv
Published
2021-12-17
Volume
144
Issue
20
Pages
8945-8950
ISSN
0002-7863 (ISSN-L)
OpenAlex
W4280543686
Cited by
151
References
1
Citations by year
2026: 17 · 2025: 30 · 2024: 42 · 2023: 45 · 2022: 17
FWCI
16.35
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of the American Chemical Society (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Vetenskapsrådet (2019-04405)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords
SARS-CoV-2 spike protein, amyloidogenesis, amyloid fibrils, amyloidogenic peptides, neutrophil elastase, endoproteolysis, COVID-19 pathogenesis, long COVID, Congo red staining, ThT fluorescence
MeSH terms
COVID-19, SARS-CoV-2, Post-Acute COVID-19 Syndrome, Amino Acid Sequence, Amyloid, Humans, Peptides, Prospective Studies, Protein Structure, Secondary, Leukocyte Elastase, Amyloidogenic Proteins, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloidogenesis of SARS-CoV-2 Spike Protein. https://app.cochat.ai/papers/10.1101/2021.12.16.472920
The paper
Nyström, S., & Hammarström, P. (2021). Amyloidogenesis of SARS-CoV-2 Spike Protein. Journal of the American Chemical Society. https://doi.org/10.1101/2021.12.16.472920

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.